WHO – Immunization coverage reaches 84%, still short of 90% goal

July 17, 2014 More than 111 million infants received vaccines in 2013 to protect them from deadly diseases. These infants account for about 84% of the world’s children, but an estimated 21.8 million infants remained unvaccinated, according to new estimates from WHO and UNICEF. The estimates tell a success story for the Expanded Programme on Immunization, namely that global coverage …

18% of Vaccinated children with Persistent Cough Have Pertussis

Research published on the 24th of June has added to concerns over the effectiveness of whooping cough vaccinations without an additional booster for school age children. The study from the Oxford University found that from a sample of 279 children, who had visited their doctor with a persistent cough lasting 2-8 weeks, 20% were confirmed as having whooping cough, also …

Newborns With Vaccinated Mothers Better Resist Whooping Cough

A study from the Baylor College of Medicine has shown that new-born children received immunity from pertussis at birth and for the first few months of their life if their mothers had received the tetanus, diphtheria and acellular pertussis (Tdap) vaccine during pregnancy. This will help to combat rising cases of whooping coughs in infants by protecting children during their …

Study Reveals the Impact of Whooping Cough Vaccination

Comprehensive study shows effect of vaccination on spread and diversification of Bordetella pertussis April 24, 2014 The most comprehensive study to date of the family of bacteria that causes whooping cough points to more effective vaccine strategies and reveals surprising findings about the bacteria’s origin and evolution. The new results could alter public health strategies to control this respiratory disease, which …

Sanofi Pasteur Announces FDA Has Expanded Age Indication of Adacel® Tdap Vaccine to Include Persons 10 Years of Age

Approval reinforces the safety profile of Adacel as an active booster immunization for the prevention of tetanus, diphtheria, and pertussis April 1, 2014 Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration (FDA) has expanded the approved age indication of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Tdap) for active …

Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene® Pertussis

March 27, 2014 Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received FDA clearance for a new molecular diagnostic test for Bordetella pertussis (B. pertussis), its fifth assay on the illumigene platform. This innovative test is the first FDA-cleared molecular stand-alone assay for B. pertussis providing a solution to the unmet need of today’s healthcare market. Often referred to as “whooping cough”, Bordetella pertussis can cause serious illness in infants, …

Texas pertussis outbreak reaches epidemic proportions

Overall pertussis numbers in the US might be in decline this year compared to last, but a current outbreak of pertussis has reached epidemic levels in Texas. This year has so far seen nearly 2,000 cases of highly infectious ‘whooping cough' reported in the state – and this figure is only set to rise. According to a Pertussis Health Alert …

Download presentation: The importance of PPP to move new concepts into clinical development

In November 2012 over 200 delegates participated in the 13th Annual World Vaccine Congress Lyon in France. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Camille Locht,  ‘The importance of PPP to move new concepts into clinical development: The …